SANOFI S.A.SANOFI S.A.SANOFI S.A.

SANOFI S.A.

No trades
See on Supercharts

Key facts today


Sanofi's Dupixent gained FDA approval as the first targeted treatment for chronic spontaneous urticaria in over ten years, potentially benefiting over 300,000 U.S. patients.
Analyze the impactAnalyze the impact
Market capitalization
‪103.81 B‬CHF
4.177CHF
‪5.23 B‬CHF
‪38.62 B‬CHF
‪1.12 B‬
Beta (1Y)
0.65
Employees (FY)
‪84.59 K‬
Change (1Y)
‪−3.41 K‬ −3.87%
Revenue / Employee (1Y)
‪456.62 K‬CHF
Net income / Employee (1Y)
‪61.09 K‬CHF

About SANOFI


CEO
Paul Hudson
Website
Headquarters
Paris
Founded
1994
ISIN
FR0000120578
FIGI
BBG006M6ZNH1
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US801060AD6
SANOFI SA 18/28
Yield to maturity
4.30%
Maturity date
Jun 19, 2028
FR1332437
SANOFI 18/38 MTN
Yield to maturity
3.60%
Maturity date
Mar 21, 2038
FR1340985
SANOFI 19/34 MTN
Yield to maturity
3.15%
Maturity date
Mar 21, 2034
FR1400Y1H
SANOFI 25/27 FLR MTN
Yield to maturity
2.86%
Maturity date
Mar 11, 2027
FR1400Y1I
SANOFI 25/31 MTN
Yield to maturity
2.77%
Maturity date
Mar 11, 2031
FR1332435
SANOFI 18/30 MTN
Yield to maturity
2.72%
Maturity date
Mar 21, 2030
FR1340984
SANOFI 19/29 MTN
Yield to maturity
2.64%
Maturity date
Mar 21, 2029
FR1350511
SANOFI 20/30 MTN
Yield to maturity
2.62%
Maturity date
Apr 1, 2030
FR14009KQ
SANOFI 22/29 MTN
Yield to maturity
2.56%
Maturity date
Apr 6, 2029
FR1320163
SANOFI 16/27 MTN
Yield to maturity
2.43%
Maturity date
Jan 13, 2027
FR1332434
SANOFI 18/26 MTN
Yield to maturity
2.38%
Maturity date
Mar 21, 2026

See all SNW bonds 


Check out other big names from the same industry as SNW.

Frequently Asked Questions


The current price of SNW is 84.371 CHF — it has decreased by −12.81% in the past 24 hours. Watch SANOFI S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange SANOFI S.A. stocks are traded under the ticker SNW.
SNW stock has fallen by −12.81% compared to the previous week, the month change is a −15.88% fall, over the last year SANOFI S.A. has showed a −7.14% decrease.
We've gathered analysts' opinions on SANOFI S.A. future price: according to them, SNW price has a max estimate of 121.42 CHF and a min estimate of 93.40 CHF. Watch SNW chart and read a more detailed SANOFI S.A. stock forecast: see what analysts think of SANOFI S.A. and suggest that you do with its stocks.
SNW reached its all-time high on Mar 3, 2025 with the price of 100.304 CHF, and its all-time low was 84.325 CHF and was reached on Dec 20, 2024. View more price dynamics on SNW chart.
See other stocks reaching their highest and lowest prices.
SNW stock is 14.69% volatile and has beta coefficient of 0.65. Track SANOFI S.A. stock price on the chart and check out the list of the most volatile stocks — is SANOFI S.A. there?
Today SANOFI S.A. has the market capitalization of ‪103.71 B‬, it has decreased by −13.92% over the last week.
Yes, you can track SANOFI S.A. financials in yearly and quarterly reports right on TradingView.
SNW net income for the last half-year is ‪3.12 B‬ CHF, while the previous report showed ‪2.16 B‬ CHF of net income which accounts for 44.06% change. Track more SANOFI S.A. financial stats to get the full picture.
Yes, SNW dividends are paid annually. The last dividend per share was 3.69 CHF. As of today, Dividend Yield (TTM)% is 4.15%. Tracking SANOFI S.A. dividends might help you take more informed decisions.
SANOFI S.A. dividend yield was 4.18% in 2024, and payout ratio reached 88.23%. The year before the numbers were 4.19% and 87.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 19, 2025, the company has ‪84.59 K‬ employees. See our rating of the largest employees — is SANOFI S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANOFI S.A. EBITDA is ‪12.35 B‬ CHF, and current EBITDA margin is 31.98%. See more stats in SANOFI S.A. financial statements.
Like other stocks, SNW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANOFI S.A. stock right from TradingView charts — choose your broker and connect to your account.